tirzepatide for the treatment of obstructive sleep apnea and obesity Why is Zepbound used Apnea? Zepbound® (tirzepatide) is approved for obstructive sleep (OSA) because it targets one most important underlying causes of the condition: obesity. OSA Sleep Apnea and Obesity: Risks,
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


























